Pancreatic Cancer Research

ResearcherFred and Pamela Buffett Cancer CenterActive in the last 2 years

Lincoln N. Strickland

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2347-4431; OpenAlex author ID A5036906585. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2022: 1 paper · 2023: 3 papers · 2024: none · 2025: none · 2026: 4 papers

Papers 8

  1. Mechanistic Insights Driving Translational Progress in Pancreatic Cancer. Co-author DOI 10.1016/j.jcmgh.2025.101685↗
  2. Dietary Fat Content Influences PanIN Progression and Pancreatic Cancer Development in Mice. Co-author DOI 10.1158/2767-9764.crc-25-0777↗
  3. Combination Immunotherapy Enhances Serial Radiofrequency Ablation Induced Systemic Antitumor Immunity in Pancreatic Cancer Co-author DOI 10.64898/2026.04.05.713683↗
  4. Pulsed Field Ablation Enables Stromal Manipulation and Tumor Reduction in Pancreatic Ductal Adenocarcinoma First author DOI 10.64898/2026.10.06.756887↗
  5. CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-22-2553↗
  6. Radiofrequency Ablation Remodels the Tumor Microenvironment and Promotes Neutrophil-Mediated Abscopal Immunomodulation in Pancreatic Cancer. Co-author DOI 10.1158/2326-6066.cir-22-0379↗
  7. The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer. Co-author DOI 10.3389/fimmu.2023.1163585↗
  8. Radiofrequency ablation in combination with CD73 inhibitor AB680 reduces tumor growth and enhances anti-tumor immunity in a syngeneic model of pancreatic ducta… First author DOI 10.3389/fonc.2022.995027↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jennifer M. Bailey · 8 shared papers, 2022–2026 · strength 1.99
  2. Nirav C Thosani · 5 shared papers, 2022–2026 · strength 0.97
  3. Erika Yanil Faraoni · 5 shared papers, 2022–2026 · strength 0.97
  4. Urvinder Kaur Sardarni · 3 shared papers, 2026 · strength 0.82
  5. Curtis Jackson Wray · 4 shared papers, 2022–2026 · strength 0.68
  6. Jesse L. Cox · 2 shared papers, 2026 · strength 0.53
  7. Khadija Shahab Turabi · 2 shared papers, 2026 · strength 0.52
  8. MacKenzie V. Demmel · 2 shared papers, 2026 · strength 0.52
  9. Florencia M. McAllister · 2 shared papers, 2023–2026 · strength 0.43
  10. Putao Cen · 2 shared papers, 2023–2026 · strength 0.39
  11. Kyle L. McAndrews · 1 shared paper, 2026 · strength 0.29
  12. Sunil R. Hingorani · 1 shared paper, 2026 · strength 0.23
  13. Dafna Bar‐Sagi · 1 shared paper, 2023 · strength 0.13
  14. Powel H. Brown · 1 shared paper, 2023 · strength 0.13
  15. Le Li · 1 shared paper, 2023 · strength 0.13
  16. Kanchan Singh · 1 shared paper, 2023 · strength 0.13
  17. Vidhi Chandra · 1 shared paper, 2023 · strength 0.13
  18. Altaf Mohammed · 1 shared paper, 2023 · strength 0.13
  19. George Van Buren · 1 shared paper, 2023 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.